Liver steatosis drives muscle atrophy in type 2 diabetes patients.

Project Information

LiSDMA

Grant agreement ID: 748944

DOI

10.3030/748944

Project closed

EC signature date 22 February 2017

Start date 21 February 2018

End date 12 April 2021

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 165 598,80

EU contribution

€ 165 598,80

Coordinated by

UNIVERSITEIT MAASTRICHT
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk

Author(s): Kenneth Pasmans, Michiel E Adriaens, Peter Olinga, Ramon Langen, Sander S Rensen, Frank G Schaap, Steven W M Olde Damink, Florian Caiment, Luc J C van Loon, Ellen E Blaak, Ruth C R Meex
Published in: Frontiers in Endocrinology, 2021, ISSN 1664-2392
Publisher: Frontiers in Endocrinology
DOI: 10.3389/fendo.2021.733625

Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes

Author(s): Ruth C.R. Meex, Ellen E. Blaak, Luc J.C. Loon
Published in: Obesity Reviews, Issue 20/9, 2019, Page(s) 1205-1217, ISSN 1467-7881
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/obr.12862